COMMUNIQUÉS West-GlobeNewswire

Motif Bio Receives Award from Cystic Fibrosis Foundation

16/01/2018 - 08:00

NEW YORK, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Motif Bio® plc (AIM:MTFB) (NASDAQ: MTFB ), a clinical-stage biopharmaceutical company specialising in developing novel antibiotics, today announced that the Company has [...]

Sales of Olainfarm Last Year Increased by at Least 4%

16/01/2018 - 07:46

Olaine, 2018-01-16 07:46 CET (GLOBE NEWSWIRE) -- December 2017, consolidated sales Sales, thsnd. EUR Changes to December 2016 Share in total sales Russia 4 471 -12% 44% Latvia 2 682 -2% 27% Ukraine 840 700% 8% Belarus [...]

Half-Year Report on DBV Technologies Liquidity Contract with Natixis

16/01/2018 - 07:31

AMF REGULATED INFORMATION Montrouge, France, January 16, 2018 Half-Year Report on DBV Technologies Liquidity Contract with Natixis Under the liquidity contract between DBV TECHNOLOGIES and NATIXIS, the following assets [...]

Bilan semestriel du contrat de liquidité DBV Technologies contractés avec Natixis

16/01/2018 - 07:31

Informations Réglementées Montrouge, France, le 16 janvier 2018, (7H30 CET) Bilan semestriel du contrat de liquidité DBV Technologies contractés avec Natixis Montrouge, France le 12 janvier 2018 - Au titre du contrat de [...]

ESPERITE (ESP) : L1 Capital subscribes to the 13th tranche of investment today

16/01/2018 - 07:17

Amsterdam, The Netherlands - 16 January 2018 Esperite N.V. (Euronext: ESP, "Esperite" or "the Group") announces that today the 13 th Tranche of EUR 250,000 is issued as a private placement of 25 convertible notes (the " [...]

Novartis new data reinforces superiority of Cosentyx® versus Stelara®* in achieving skin clearance for psoriasis patients

16/01/2018 - 07:16

Results from CLARITY study show Cosentyx ® (secukinumab) was significantly more effective than Stelara ®* (ustekinumab) in delivering clear and almost clear skin at 12 weeks and at 16 weeks [1] Data support findings [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

16/01/2018 - 07:11

REGULATED INFORMATION GHENT, Belgium, 16 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

16/01/2018 - 07:01

REGULATED INFORMATION GHENT, Belgium, 16 January 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

NEOVACS : STRENGTHENED ITS INTELLECTUAL PROPERTY IN RUSSIA

16/01/2018 - 07:01

NEOVACS STRENGTHENED ITS INTELLECTUAL PROPERTY IN RUSSIA This patent covers IFNalpha kinoid and its application in all diseases related to an overproduction of IFNalpha cytokine Paris and Boston, January 16 th 2018, 07: [...]

NEOVACS : RENFORCE SA PROPRIÉTÉ INTELLECTUELLE EN RUSSIE

16/01/2018 - 07:01

NEOVACS RENFORCE SA PROPRI É T É INTELLECTUELLE EN RUSSIE Ce brevet porte sur l'IFNalpha Kinoïde et son utilisation dans les maladies liées à la surproduction de la cytokine IFNalpha Paris et Boston, le 16 janvier 2018 [...]

Sandoz regulatory submission for proposed biosimilar adalimumab accepted by FDA

16/01/2018 - 07:01

Adalimumab is an anti-TNF medicine used to treat a range of immunological diseases[1] The comprehensive data package provided is expected to demonstrate that Sandoz proposed biosimilar adalimumab matches the reference [...]

Cannabis Wheaton Income Corp. Accelerates Warrant Expiry Date for Anticipated Proceeds of $57.7 Million

16/01/2018 - 06:36

VANCOUVER, British Columbia, Jan. 16, 2018 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX-V: CBW ) (" Wheaton Income " or the " Company ") announced today that the Company has elected to [...]

Recording of the Third Quarter 2017 Investor Conference Webinar

15/01/2018 - 21:06

Olaine, 2018-01-15 21:06 CET (GLOBE NEWSWIRE) -- During the webinar, Salvis Lapiņš received a question on the amount of receivables overdue for 90 and more days that are unprovided for. The amount totaled 1.4 million [...]

Express Scripts Holding Company Announces Fourth Quarter and Full Year 2017 Earnings Conference Call

15/01/2018 - 19:54

St. Louis, Jan. 15, 2018 (GLOBE NEWSWIRE) -- Express Scripts Holding Company (Nasdaq: ESRX) (“ Express Scripts ”) announced today its intention to release its 2017 fourth quarter and full year financial results on [...]

Sanofi : Disclosure of trading in own shares

15/01/2018 - 17:47

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/09271106-32d7-4990-bec5-164383c0e961

Sanofi : Déclaration des transactions sur actions propres

15/01/2018 - 17:47

Attachments: http://www.globenewswire.com/NewsRoom/AttachmentNg/46b31b46-f046-4052-a2a6-27a37a1b1287

SPINEWAY : 1st complex surgery performed in the USA with Spineway's MIS implants

15/01/2018 - 17:46

Press release Ecully, 15 January 2018 1 st complex surgery performed in the USA with Spineway's MIS implants Spineway, specialist in surgical implants and instruments for treating disorders of the spinal column (spine [...]

SPINEWAY : 1ère opération d'une chirurgie complexe réalisée aux USA avec les implants MIS de Spineway

15/01/2018 - 17:46

Communiqué de presse Ecully, le 15 janvier 2018 1 ère opération d'une chirurgie complexe réalisée aux USA avec les implants MIS de Spineway Spineway, spécialiste des implants et ancillaires chirurgicaux pour le [...]

John Baker, MD is Honored by the American Health Council for “Best in Medicine”

15/01/2018 - 17:15

NEW YORK, Jan. 15, 2018 (GLOBE NEWSWIRE) -- The American Health Council is honored to name John Baker, MD as one of America’s “Best in Medicine.” Owner and head surgeon of Allegiance Orthopedic and Spine Institute, his [...]